Page last updated: 2024-09-03

iodoazomycin arabinoside and misonidazole

iodoazomycin arabinoside has been researched along with misonidazole in 3 studies

Compound Research Comparison

Studies
(iodoazomycin arabinoside)
Trials
(iodoazomycin arabinoside)
Recent Studies (post-2010)
(iodoazomycin arabinoside)
Studies
(misonidazole)
Trials
(misonidazole)
Recent Studies (post-2010) (misonidazole)
27161,562139210

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chapman, JD; Roa, WH1
Stypinski, D; Wiebe, LI1
Cheeseman, C; Khlebnikov, V; Kumar, P; Liang, H; Shustov, G; Wiebe, LI; Yang, XH; Zheng, W1

Reviews

1 review(s) available for iodoazomycin arabinoside and misonidazole

ArticleYear
Pharmacokinetics of SPECT radiopharmaceuticals for imaging hypoxic tissues.
    The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 1996, Volume: 40, Issue:3

    Topics: Animals; Cell Hypoxia; Humans; Iodine Radioisotopes; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Radiopharmaceuticals; Technetium; Tomography, Emission-Computed, Single-Photon

1996

Other Studies

2 other study(ies) available for iodoazomycin arabinoside and misonidazole

ArticleYear
Killing of EMT-6 cells by decays from isotopes incorporated on sensitizer adducts.
    Radiation research, 1992, Volume: 132, Issue:2

    Topics: Animals; Cell Death; Cell Hypoxia; Cell Survival; Cobalt Radioisotopes; Gamma Rays; Iodine Radioisotopes; Kinetics; Mice; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors; Tritium; Tumor Cells, Cultured

1992
Design, synthesis, and preliminary biological evaluation of 6-O-glucose-azomycin adducts for diagnosis and therapy of hypoxic tumors.
    Journal of medicinal chemistry, 2012, Jul-12, Volume: 55, Issue:13

    Topics: Cell Hypoxia; Cell Line, Tumor; Drug Design; Glucose Transport Proteins, Facilitative; Glucosides; Glycosides; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Misonidazole; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Radionuclide Imaging; Radiopharmaceuticals; Transcriptional Activation

2012